PMID: 6168642Apr 1, 1981Paper

Inhibition of cell division by interferon: changes in cell cycle characteristics and in morphology of Ehrlich ascites tumour cells in culture

Journal of Cell Science
L R Panniers, M J Clemens

Abstract

The rate of division of Ehrlich ascites tumour cells in culture is inhibited by mouse interferon. A 75% reduction in cell number is achieved after 3 days and this effect is species specific. The growth inhibition is associated with a marked increase in modal cell volume and with extensive changes in cellular morphology. The cells also become more resistant to detachment from the substratum by mild trypsin treatment. Analysis of the duration of specific phases of the cell cycle indicates prolongation of mitosis (by 150%), G2 (by 44%) and S-phase (by 100%), but a slight shortening of G1, as a result of interferon treatment. There is also a dramatic rise in the proportion of cells in culture which contain 2 or more nuclei. As a result of these changes, together with the increase in cell size, the mean cellular contents of protein, RNA and DNA are considerably elevated. There is a small but significant increase in 3'5' cyclic AMP (cAMP) content of Ehrlich cells after exposure to interferon, and exogenous cAMP or its analogues cause morphological changes similar to those elicited by interferon. However, many of the other effects of the latter are not mimicked by the cyclic nucleotide, suggesting that cAMP is only involved in part of...Continue Reading

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.